Peptide macrocycles against acinetobacter baumannii
US-2024050516-A1 · Feb 15, 2024 · US
Conformations of divergent peptides with mineral binding affinity
US9415114B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9415114-B2 |
| Application number | US-201514805588-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 22, 2015 |
| Priority date | Apr 21, 2011 |
| Publication date | Aug 16, 2016 |
| Grant date | Aug 16, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A series of peptides with divergent confirmations including structures of formula (1A), (1B), (2) and (3) are provided. In the formula, wherein U, G, A, B, R1, R2 and T are as defined in the specification. The divergent peptides disclosed in the present invention are characterized in a mineral binding affinity function.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical composition, comprising a pharmaceutically acceptable carrier and an effective amount of a compound having a formula 3: wherein R1 is -(Asp-)K, R2 is one selected from a group consisting of a polyamindoamine dendrimer (PAMAM), a polyester type dendrimer, a polyglycerol dendrimer, a triazine based dendrimer, a poly(propyleneimine)dendrimer and a Newkome-type dendrimer, where 64≧T≧1, 20≧K≧1, where T and K are natural numbers, Asp represents an aspartic acid, and Gly represents a glycine. 2. A divergent compound, comprising a structure having a formula 3: wherein R1 is -(Asp-)K, R2 is one selected from a group consisting of a polyamindoamine dendrimer (PAMAM), a polyester type dendrimer, a polyglycerol dendrimer, a triazine based dendrimer, a poly(propyleneimine)dendrimer and a Newkome-type dendrimer, where 64≧T≧1, 20≧K≧1, T and K are natural numbers, Asp represents an aspartic acid, and Gly represents a glycine. 3. A divergent compound as claimed in claim 2 , wherein R2 is a polyamindoamine dendrimer (PAMAM).
Assignees
Inventors
Classifications
- C07K5/0815Primary
with the first amino acid being basic · CPC title
Polymers modified by chemical after-treatment · CPC title
- C08G73/028Primary
Polyamidoamines · CPC title
- A61K47/48207Primary
Human Necessities · mapped topic
Tripeptides · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9415114B2 cover?
- A series of peptides with divergent confirmations including structures of formula (1A), (1B), (2) and (3) are provided. In the formula, wherein U, G, A, B, R1, R2 and T are as defined in the specification. The divergent peptides disclosed in the present invention are characterized in a mineral binding affinity function.
- Who is the assignee on this patent?
- Univ Kaohsiung Medical
- What technology area does this patent fall under?
- Primary CPC classification C07K5/0815. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).